Physician profile
Kaylie Devall
NPI 1093576753
$1,008.01
in general payments reported to CMS, 2019-2025
16 companies · $784 in 2025
The $784 reported for 2025 was more than what 92% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $224 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $305.66 | 2025 | Qelbree |
| Corium, LLC | $173.41 | 2024-2025 | Azstarys |
| Glaxosmithkline, LLC. | $86.24 | 2024-2025 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $55.73 | 2024-2025 | |
| Sanofi Pasteur INC. | $53.98 | 2025 | |
| Noven Therapeutics, LLC | $49.65 | 2025 | Xelstrym |
| Aytu Biopharma, INC. | $47.91 | 2024-2025 | Karbinal |
| Collegium Pharmaceutical, INC. | $45.97 | 2025 | Jornay Pm |
| Tris Pharma INC | $44.13 | 2024-2025 | Dyanavel Xr |
| Ars Pharmaceuticals Operations, INC. | $26.90 | 2025 | Neffy |
| Krystal Biotech INC | $23.66 | 2024 | Vyjuvek |
| Cipher Pharmaceuticals US LLC | $23.40 | 2025 | Natroba, Spinosad |
| Sanofi-Aventis U.S. LLC | $21.40 | 2024 | |
| Lnhc, INC | $19.51 | 2025 | Zelsuvmi |
| Cumberland Pharmaceuticals, INC. | $15.37 | 2025 | Kristalose |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.09 | 2024 | Gardasil, Vaxneuvance, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylie Devall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.